Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas


Por: Li, H, Pemov, A, Allaway, R, Muir, DF, Chang, LJ, Banerjee, J, Scott, AJ, Nagy, JMW, Liu, J, Carrió, M, Mazuelas, H, Yachnis, A, Lee, SY, Zhang, XC, Lyu, Y, Stewart, DR, Hirbe, A, Blakeley, JO, Serra, E, Wallis, D and Wallace, MR

Publicada: 21 ene 2026
Resumen:
Neurofibromatosis type 1 (NF1) is an autosomal dominant condition in which patients are heterozygous for a disruptive pathogenic variant in the NF1 gene. The most characteristic feature of the condition NF1 is the neurofibroma, a benign, multi-cellular tumor which initiates when a cell of the Schwann cell lineage gains a somatic pathogenic variant of the other NF1 allele. Neurofibromas developing at nerve termini in the skin are termed "cutaneous" neurofibromas (cNFs), while those developing within larger nerves are termed "plexiform." Most patients develop cNFs beginning in late childhood or early adulthood, continuing throughout life at variable rates. Some patients may develop only a few cNFs, while others suffer from thousands. There are no reliably effective physical or pharmaceutical therapies besides surgical removal. Although these are not life-threatening, they are disfiguring and can interfere with normal life functions. To provide a resource for research, we developed short-term cNF Schwann cell cultures from NF1 patients, from which we subsequently established the first semi-immortalized cNF cell lines through transduction with wild-type human telomerase reverse transcriptase (hTERT) and murine cyclin-dependent kinase 4 (mCdk4) genes. Here we present molecular, cellular, and functional characterization of these cell lines, which will be of utility for investigating and developing NF1 cNF therapies.

Filiaciones:
Li, H:
 Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA

Pemov, A:
 NCI, Div Canc Epidemiol & Genet, Clin Genet Branch, NIH, Rockville, MD 20852 USA

Allaway, R:
 Sage Bionetworks, Seattle, WA USA

Muir, DF:
 Univ Florida, Dept Pediat, Div Neurol, Gainesville, FL USA

Chang, LJ:
 Shenzhen Geno Immune Med Inst, Shenzhen, Peoples R China

Banerjee, J:
 Sage Bionetworks, Seattle, WA USA

Scott, AJ:
 Sage Bionetworks, Seattle, WA USA

Nagy, JMW:
 Univ Iowa, Stead Family Dept Pediat, Iowa City, IA USA

Liu, J:
 Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA

:
 Germans Trias I Pujol Res Inst, Badalona, Barcelona, Spain

:
 Germans Trias I Pujol Res Inst, Badalona, Barcelona, Spain

Yachnis, A:
 Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL USA

Lee, SY:
 Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD USA

Zhang, XC:
 Washington Univ, Dept Med, Div Oncol, Sch Med, St Louis, MO USA

Lyu, Y:
 Washington Univ, Dept Med, Div Oncol, Sch Med, St Louis, MO USA

Stewart, DR:
 NCI, Div Canc Epidemiol & Genet, Clin Genet Branch, NIH, Rockville, MD 20852 USA

Hirbe, A:
 Washington Univ, Dept Med, Div Oncol, Sch Med, St Louis, MO USA

 Washington Univ, Sch Med, Siteman Canc Ctr, St Louis, MO USA

Blakeley, JO:
 Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD USA

:
 Germans Trias I Pujol Res Inst, Badalona, Barcelona, Spain

Wallis, D:
 Univ Alabama Birmingham, Dept Genet, Birmingham, AL USA

Wallace, MR:
 Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32611 USA
ISSN: 19326203





PLoS ONE
Editorial
Public Library of Science, 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA, Estados Unidos America
Tipo de documento: Article
Volumen: 21 Número: 1
Páginas:
WOS Id: 001680191100006
ID de PubMed: 41564118
imagen Green Submitted, gold

MÉTRICAS